Novartis
NVS
910 hedge funds and large institutions have $19.9B invested in Novartis in 2017 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 342 increasing their positions, 336 reducing their positions, and 61 closing their positions.
25% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 61
9% more capital invested
Capital invested by funds: $18.2B → $19.9B (+$1.66B)
2% more repeat investments, than reductions
Existing positions increased: 342 | Existing positions reduced: 336
0.73% more ownership
Funds ownership: 10.63% → 11.36% (+0.73%)
1% more funds holding
Funds holding: 905 → 910 (+5)
5% less funds holding in top 10
Funds holding in top 10: 21 → 20 (-1)
56% less call options, than puts
Call options by funds: $31.5M | Put options by funds: $72M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$362M |
| 2 |
Parnassus Investments
San Francisco,
California
|
+$287M |
| 3 |
BlackRock
New York
|
+$211M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$130M |
| 5 |
Millennium Management
New York
|
+$102M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$205M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$104M |
| 3 |
ClearBridge Investments
New York
|
-$81.5M |
| 4 |
Lazard Asset Management
New York
|
-$47.6M |
| 5 |
MHI
Miller Howard Investments
Kingston,
New York
|
-$46.6M |
NVS Hedge Fund Activity: Q1 2017 in Review
910 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q1 2017, worth a combined $19.9B — up 9.1% from $18.2B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new NVS positions and 61 closed out — a net gain of 15 holders — while 342 added to existing stakes and 336 trimmed.
The largest buyer was Dodge & Cox, adding an estimated $362M. The largest seller was 1832 Asset Management, cutting an estimated $205M.
- 910 institutional investors held Novartis (NVS) as of Q1 2017, up from 905 in Q4 2016.
- Funds reported $19.9B of Novartis stock for Q1 2017, up 9.1% quarter-over-quarter.
- 76 funds opened new Novartis positions in Q1 2017 and 61 closed out, a net change of +15 holders.
- The largest Novartis buyer in Q1 2017 was Dodge & Cox, an estimated $362M added.
- The largest Novartis seller in Q1 2017 was 1832 Asset Management, an estimated $205M sold.
Based on aggregated 13F filings for Q1 2017.